v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities    
Net income $ 23,535 $ 18,005
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 11,471 11,137
Amortization of deferred debt issuance costs 245 250
Stock compensation expense 3,365 2,576
Deferred income taxes (1,170) (1,507)
Remeasurement (gain)/loss on intercompany balances (325) 327
Changes in operating assets and liabilities:    
Accounts receivable 10,668 13,097
Inventories (20,487) (6,985)
Contract assets and liabilities (8,973) (6,277)
Other current and non-current assets (4,155) (5,230)
Accounts payable 9,123 (685)
Accrued liabilities and non-current liabilities (3,052) (2,338)
Income taxes payable and receivable (2,078) (1,149)
Net cash provided by operating activities 18,167 21,221
Investing activities    
Purchases of property, plant and equipment (5,485) (5,785)
Sale of rental equipment 81 36
Net cash used in investing activities (5,404) (5,749)
Financing activities    
Proceeds from revolving credit facility 31,711 0
Payments on revolving credit facility (17,011) 0
Proceeds from long-term debt 125,000 0
Payments on long-term debt (138,875) (6,750)
Issuance costs associated with revolving line of credit and long-term debt (1,085) 0
Repurchase of employee stock units on vesting (3,352) (3,012)
Repurchase of shares under authorized program (15,774) (3,838)
Payments on finance leases (95) (59)
Net cash used in financing activities (19,481) (13,659)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 779 454
Change in cash, cash equivalents and restricted cash (5,939) 2,267
Cash, cash equivalents and restricted cash at beginning of period 41,422 50,431
Cash, cash equivalents and restricted cash at end of period $ 35,483 $ 52,698

Source

PDF HTML 10-Q Filing
ZIP HTML XBRL